Our Opinion

eFFECTOR Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“While we expect to file the results of the 13-week animal toxicology studies with the FDA by the end of 2021, if we do not complete these toxicology studies on our expected timeline or if the results of the studies do not support a continued development, this may cause the trial to be delayed or not completed at all.” (Page 13) Read the full document

Company Description

eFFECTOR Therapeutics, Inc., formerly Locust Walk Acquisition Corp, is a clinical-stage biopharmaceutical company. The Company focuses on the development of oncology drugs named selective translation regulator inhibitors (STRIs).

Company Website: https://effector.com